Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10123734 | British Journal of Anaesthesia | 2005 | 9 Pages |
Abstract
The evidence provided by the existing studies is both inadequate and inconsistent. There is insufficient evidence to offer reliable recommendations on the clinical use of dopexamine for the protection of either hepatosplanchnic or renal perfusion in high-risk surgical patients. Furthermore, there is no current evidence to support a role for dopexamine in protecting either hepatosplanchnic or renal perfusion in critically ill patients.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
M.C. Renton, C.P. Snowden,